Skip to main content
BMJ Open logoLink to BMJ Open
. 2016 Aug 4;6(8):e011022. doi: 10.1136/bmjopen-2015-011022

Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women

Mahirah Ma'som 1, Nirmala Bhoo-Pathy 2,3, Nazrila Hairizan Nasir 4, Jerome Bellinson 5, Shridevi Subramaniam 2, Yuntong Ma 6, Siew-Hwei Yap 7, Pik-Pin Goh 2, Patti Gravitt 8, Yin Ling Woo 1,7
PMCID: PMC4985871  PMID: 27491667

Abstract

Objective

The objective of this study was to determine the attitudes and acceptability of self-administered cervicovaginal sampling compared with conventional physician-acquired Papanicolaou (Pap) smear among multiethnic Malaysian women.

Method

A cross-sectional study was carried out via interviewer-administered surveys from August 2013 through August 2015 at five government-run, urban health clinics in the state of Selangor. Subjects were participants from an ongoing community-based human papillomavirus (HPV) prevalence study who answered a standard questionnaire before and after self-sampling. The cervicovaginal self-sampling for HPV genotyping was performed using a simple brush (‘Just for Me’; Preventive Oncology International, Hong Kong). Detailed data on sociodemographics, previous Pap smear experience, and attitudes towards self-administered cervicovaginal sampling were collected and analysed. Acceptability was inferred using a five-item Likert scale that included six different subjective descriptives: experience, difficulty, convenience, embarrassment, discomfort or pain, and confidence in collecting one's own sample.

Results

Of the 839 participants, 47.9% were Malays, followed by 30.8% Indians, 18.8% Chinese and 2.5% from other ethnicities. The median age of the participants was 38 years (IQR 30–48). Some 68.2% of participants indicated a preference for self-sampling over the Pap test, with 95% indicating willingness to follow-up a positive result at the hospital. Age, ethnicity and previous Pap test experience were significant independent factors associated with preference for self-sampling. The older the individual, the less likely they were to prefer self-sampling (adjusted OR 0.94, 95% CI 0.90 to 0.98). The Chinese were less likely to prefer self-sampling (72.6%) than the Malays (85.1%) (adjusted OR 0.57, 95% CI 0.33 to 0.98, p=0.004). Participants who had never undergone a Pap smear were also more likely to prefer self-sampling (88.5%) than women who had undergone a previous Pap (80.9%) (adjusted OR 0.06, 95% CI 0.35 to 0.87).

Conclusions

Overall, urban Malaysian women from multiethnic backgrounds found self-sampling to be an acceptable alternative to Pap smear.

Keywords: human papillomavirus, pap smear, cervical cancer screening, self sampling, cervico-vaginal sampling


Strengths and limitations of this study.

  • This is one of the largest studies to systematically assess the acceptability of cervicovaginal self-sampling as an alternative to Papanicolaou (Pap) smear in a population with low screening uptake.

  • The study cohort consisted of a convenience sample from healthcare clinics, possibly introducing bias, as it excluded those who may not attend healthcare facilities for a variety of reasons.

  • This study could not assess and compare the sensitivity and specificity of the screening methods—that is, human papillomavirus genotyping versus Pap smear.

  • The attitudes of those who declined to join the study may have introduced bias to the results.

Introduction

Cervical cancer is the second most common cancer among Malaysian women with an incidence of over 16 per 100 000 and mortality of over 8 per 100 000.1 2 While there is no population-based cervical cancer screening programme in Malaysia, the government has supported opportunistic screening by providing free Pap smear tests since 1995. The uptake of Papanicolaou (Pap) tests among Malaysian women remains suboptimal, with less than half (47.3%) of the population having undergone one.3 Many reasons have been cited for the lack of participation in cervical cancer screening, including cost, embarrassment, fear, lack of knowledge and lack of time.4–7 In 2010, the Malaysian government started a national school-based human papillomavirus (HPV) immunisation programme.8 Despite the success of the national HPV vaccine programme, with more than 90% of 13-year-old school girls being vaccinated,9 more comprehensive coverage and increased uptake of cervical screening remains important for at least another 30–40 years to adequately prevent the development of cervical cancer in the Malaysian population.

In communities where uptake of conventional cervical screening by cytology has been low, self-sampling may offer an attractive alternative. Unlike Pap smear tests, this procedure can be carried out by the individual themselves without the help of a physician or medical staff. This means that other logistical barriers involved with Pap test screenings, such as long waiting times in hospitals, inadequate number of and inexperienced cytologists, and unequal distribution of healthcare resources,10 can be overcome, making it a more efficient and cost-effective option.11 12 There is a variety of self-samplers available which allows different methods of screening for cervical cancer. Generally, they are divided into brush-based and lavage-based self-sampling devices most commonly used for HPV genotyping but are also suitable for cervical cytology and detection of biomarkers associated with cervical premalignant or malignant diseases.13 14 Studies have shown a rise in participation from non-respondents to screening programmes when self-sampling methods are introduced.15–20 However, owing to sociocultural and religious differences, it was important to assess the value of self-sampling in a multiethnic Asian community such as Malaysia. This study aimed to explore the attitudes and perception before and after the process of self-sampling for HPV genotyping to determine acceptability in comparison with the Pap smear test among a multiethnic population.

Method

Participants

Volunteers for this cross-sectional study were recruited via convenience sampling between August 2013 and August 2015 from five government-run general practice clinics (Klinik Kesihatan Pandamaran, Klinik Kesihatan Ampang, Klinik Kesihatan Bandar Botani, Klinik Kesihatan Batu 9, and University Malaya Medical Centre), which are located in Selangor, the most developed state in Malaysia with a high level of urbanisation. Subjects were participants from an ongoing community-based HPV prevalence study (The Malaysian HPV Prevalence Study), who were recruited during their visits to the health clinics for primary care services, including immunisation and routine health checks, and while accompanying family members to these clinics. Participants aged between 18 and 60 years old who agreed to perform self-sampling joined this study. The exclusion criteria were pregnancy, menstruation, acute illness or never having been sexually active. This study received approval from the Medical Research Ethics Committee (NMRR-13-444-14609) and the University of Malaya Medical Ethics Committee (MREC989.32). Written informed consent was obtained from all participants. All patient responses were kept confidential.

Cervicovaginal self-sampling and assessment

Participants were invited to perform self-sampling on their own using a simple brush (‘Just for Me’; courtesy of Preventive Oncology International, Hong Kong). An image of the brush can be seen in figure 1. Instructions on how to use the self-sampler were given to the participants. Briefly, participants were instructed to gently push the brush to the top of the vagina with one leg on a chair. The brush is turned a few times to the left and then the right before being removed completely. After withdrawal, the brush is rubbed on to the Preventive Oncology International FTA® card provided with the kit and sealed in an envelope. The FTA® card is a solid media specimen transport card and therefore eliminates problems encountered with alcohol-based liquids, temperature exposure and transportation difficulties.21 A questionnaire developed in a previous study22 was modified and translated into Malay and Mandarin so it could be applied to our multilingual population (see online supplementary material file). It was administered before and after the procedure. The preassessment was intended to evaluate the initial response of the participants when they were introduced to the kit and later compared with their actual experience, which was recorded during the post-assessment. Acceptability indices for the self-administered cervicovaginal sampling included six items: experience, difficulty, convenience, embarrassment, discomfort or pain, and confidence (as shown in table 1). A five-item Likert scale was used in the pre- and post-self-sampling questionnaire, where 5 was the most favourable response and 1 the most disagreeable. A positive response towards self-sampling (deemed as acceptable) was defined based on participant responses of 4 or 5 points using the Likert scale. After self-sampling, we also inquired about participants' preference for HPV testing: prefer self-sampling; no preference (agreeable to both); prefer Pap testing. Sociodemographic information was collected via interviewer-administered questionnaire and included information on age, ethnicity, highest attained education, marital status, smoking status and previous Pap testing experience.

Figure 1.

Figure 1

The ‘Just for Me’ self-administered cervicovaginal sampling brush, courtesy of Preventive Oncology International, Hong Kong.

Table 1.

Indices of the five-item Likert scale for each of the categories

Likert scale 1 2 3 4 5
Experience Very bad Bad Neither Good Very good
Difficulty Very hard Hard Neither Easy Very easy
Convenience Very inconvenient Inconvenient Neither Convenient Very convenient
Embarrassment Very embarrassed Embarrassed Neither Not embarrassed Not embarrassed at all
Discomfort/pain Severe discomfort/pain Some discomfort/pain Neither No discomfort/pain No discomfort/pain at all
Confidence Not at all confident Unconfident Neither Confident Very confident
Supplementary data

bmjopen-2015-011022supp.pdf (85.2KB, pdf)

Statistical analysis

Cronbach's α coefficient which ranges from 0 to 1 was used to ascertain internal consistency of the questionnaire. A low value shows poor reliability or consistency among the items within the construct and a value of at least 0.7 is generally needed to show good reliability. McNemar's test was used for correlated proportions to measure any significance in the change of acceptability after self-sampling. Categorical variables were compared using χ2. Continuous variables were described using medians, as most of the variables were assumed to be not normally distributed in the population, and compared using the Mann-Whitney U test. Participants who indicated that they preferred self-sampling as well as those who did not have any preference (agreeable to both methods) were categorised into ‘prefer self-sampling’ and compared against participants who preferred the Pap test. Multivariable logistic regression analysis including age, highest attained education, ethnicity, marital status, smoking status and previous Pap testing experience was conducted to determine independent predictors of preference for self-sampling. A p value of <0.05 was considered to be significant. Data was analysed using SPSS V.20.

Results

Participant characteristics

A total of 839 women were interviewed and the median age of the study participants was 38 years (IQR 30–48). Most (82.7%) of the study population were premenopausal, aged 50 years old and below. Malay women represented the largest ethnic group (47.9%), followed by Indians (30.8%), Chinese (18.8%) and other races (2.5%), with 86.3% being married. Over half (57%) of the participants were employed, while 35.2% were fulltime home-makers. Secondary education had been completed by 62.1%. Only 11.8% of women reported a monthly household income of more than RM5000 (US$1100). Out of the 839 women, 76% had heard of the Pap smear before, with 63.1% having undergone a Pap test. Most of the women (81.9%) who had undergone a Pap smear test did so in the 5 years preceding the study.

Factors positively associated with previous experience of Pap testing include higher education level (p<0.05), older age (p<0.05) and higher income (p<0.05). Of the women who had never undergone a Pap test, primary barriers stated were lack of awareness (13%), lack of time (10%), no existing symptoms (6.6%) and fear (5.1%) (data not shown).

Self-administered cervicovaginal sampling is acceptable

Both pre- and post-questionnaires showed a high internal consistency, with a Cronbach's α value of 0.796 for the pre-questionnaire and 0.862 for the post-questionnaire. In the pre-questionnaire, more than half of the participants gave a positive response (score 4 or 5 on the Likert scale) for all six items tested: experience, ease of procedure, convenience, embarrassment, comfort and confidence. Table 2 shows the pre- and post-test proportions of women who found self-sampling acceptable (answered 4 or above on the Likert scale). Most women's perceptions changed significantly after experiencing self-sampling in that, after self-sampling, most reported the procedure to be easy (84.5%), convenient (86.3%) and not painful (78.2%) and expressed confidence about collecting their own samples correctly (79.6%).

Table 2.

Percentage of women who found self-sampling acceptable (answered 4 or above on the Likert scale)

Pre-questionnaire, N (%) Post-questionnaire, N (%) p Value*
Good experience 588 (70.1) 686 (81.7) 0.004
Easy to do 570 (67.9) 709 (84.5) <0.001
Very convenient 647 (77.1) 724 (86.3) 0.021
Not embarrassing 716 (85.3) 740 (88.2) 0.267
No discomfort 426 (50.8) 656 (78.2) <0.001
Very confident 567 (67.6) 668 (79.6) 0.003
Overall median score 4.333 4.833

*Derived using McNemar's test. p Values <0.05 were considered significant.

Overall, the above findings indicate that there was an increase in all six indices of acceptability after self-sampling. In the post-questionnaire, it was also revealed that the vast majority (91.8%) of the participants would be willing to self-sample if it was made the only cervical cancer screening option available. Most (95.2%) participants expressed willingness to go for a follow-up should they obtain a positive result. Approximately two-thirds (60.0%) preferred to carry out self-sampling at home, and almost half (49.1%) would prefer to pick up the self-sample kit at a nearby clinic.

Self-sampling versus conventional Pap test

After the procedure, 68.2% of the participants were reported to have a preference for self-sampling compared with 13.5% who preferred Pap smear tests, while 14.1% stated no preference (agreeable to both methods). There were no significant differences in preference for self-sampling based on education level, smoking and marital status (table 3). Women who preferred self-sampling were significantly younger than their counterparts who preferred the Pap test. Ethnicity also influenced preference for self-sampling, with the Chinese less likely to prefer self-sampling than the Malays (OR 0.57, 95% CI 0.33 to 0.98). For a sensitivity analysis, the group of women were split into those who had and had not previously undergone Pap tests. It was found that prior experience of undergoing a Pap test had a significant impact on the preference (p=0.01). Among the women with no prior experience of Pap testing, self-administered cervicovaginal sampling was preferred over physician sampling in 75% of participants.

Table 3.

Factors associated with preference for self-sampling

Participant characteristic Overall (N) Preferred self-sampling Preferred Pap test p Value* OR† 95% CI
Age 38 37 (30–47) 43 (31–52) 0.001‡ 0.98‡ 0.96 to 1.00
Education level
 Basic 89 77 (86.5) 12 (13.5) 0.714 1.00§
 Secondary 436 362 (83.0) 74 (17.0) 0.72 0.35 to 1.48
 Tertiary and above 160 133 (83.1) 27 (16.9) 0.67 0.30 to 1.52
Ethnicity
 Malay 335 285 (85.1) 50 (14.9) 0.004‡ 1.00§
 Indian 213 183 (85.9) 30 (14.1) 1.09 0.65 to 1.83
 Chinese 117 85 (72.6) 32 (27.4) 0.57‡ 0.33 to 0.98
 Other 20 19 (95.0) 1 (5.0) 2.24 0.29 to 17.55
Marital status
 Single 82 66 (80.5) 16 (19.5) 0.433 1.00§
 Married 603 506 (83.9) 97 (16.1) 1.41 0.76 to 2.60
Smoking
 Never 642 532 (82.9) 110 (17.1) 0.112 1.00§
 Current or former 40 37 (92.5) 3 (7.5) 2.38 0.70 to 8.13
Previous Pap experience
 Yes 434 351 (80.9) 83 (19.1) 0.010‡ 1.00§
 No 243 215 (88.5) 28 (11.5) 1.46 0.88 to 2.41

Values are median (IQR) or N (%).

2 test was used to compare categorical variables, whereas the Mann-Whitney test was used to compare age.

†OR for preference for self-sampling compared with preference for Pap testing, derived using a multivariable logistic regression model mutually adjusted for age, highest attained education, ethnicity, marital status, smoking status and previous Pap test experience.

‡Results were considered to be significant, as the p value was <0.05, or 95% CI for OR did not include 1.00.

§Reference indicator.

Discussion

To our knowledge, this is one of the largest studies where acceptability of self-sampling was systematically assessed before and after the procedure was carried out in a multiethnic Southeast Asian population. In this study, 98% of the participants were within the screening age population (21–65 years old), where 40% of the participants had not undergone a Pap test in the past 3 years or more, and 36% of participants had never had a Pap test. Cervical cancer, the second most prevalent cancer among Malaysian women, is preventable, and an estimated 70% of new cases can be prevented by screening and early detection.23 24 Unfortunately, the overall uptake of the Pap smear in Asian countries, including Malaysia, is still poor.4–7 25 Lack of awareness was the main reason cited by the participants in this study for never having undergone Pap smear tests before this. This is also the most commonly cited reason in other countries such as Turkey, Bangladesh, Gabon and Korea.26–29 Therefore, increasing awareness of and education about cervical cancer screening is necessary and independent of the modality of screening. While self-swabs and other self-sampling devices have been examined and reported to be reliable6 and not inferior to specimens obtained by physicians,30 it is necessary to investigate the perception and acceptability of self-sampling among multiethnic Malaysian women, especially potential users who have never undergone Pap testing.

Generally, participants found self-sampling to be highly acceptable. Negative perceptions regarding the use of self-sampling reported before experience with collection decreased after having experienced the self-collection first-hand. The acceptability scores indicated that the participants were highly confident in collecting their own samples. This is similar to studies undertaken in Sub-Saharan Africa31 and Finland.19 Interestingly, in studies where physician sampling was compared directly with self-sampling, women trusted the physician sampling more and had lower confidence in their own competency.22 32 In our study, the level of education was significantly associated with confidence, and, surprisingly, those with a higher level of education were less confident about self-collection. There could be several explanations for this. It can be postulated that those with a higher education tend to overthink and question their abilities more. Education programmes designed to show the validity of self-collection may help to alleviate any concerns raised by doubtful participants. Another reason could be that women with higher education were more comfortable with a professional carrying out the test rather than themselves. This is contradictory to studies showing that education level did not have a significant impact on self-sampling acceptability.33 The majority (68.2%) of the women surveyed preferred self-sampling compared with physician-sampled Pap smear tests after carrying it out. This is not surprising, as issues such as embarrassment and inconvenience could be overcome with the use of self-samplers, enabling women to do it independently in the comfort of their own homes. These results are in line with those of previous studies.22 34–38 However, prior experience with Pap testing or the absence of any previous experience may have influenced this decision. The results indicated that physician sampling was less likely to be preferred than self-administered cervicovaginal sampling for women who have never undergone Pap testing. This result matched a similar study25 in which patients with no history of Pap testing were more inclined to self-sampling. This finding has important implications, as one of the target groups for improving cervical screening rates is non-attendees or those that have not participated in screening in any form.

It is worth noting that the different religions and cultures among Malaysian women did not influence the acceptability of self-sampling. This is in agreement with previous findings,39 40 which also reported that cultural or religious beliefs were not a barrier to screening participation. Although in agreement with these findings, Padela et al41 noted that there was a fatalistic attitude related to negative religious coping, whereby individuals felt that health issues were a penance from God, which resulted in decreased willingness to undergo Pap testing. Therefore, while religious beliefs did not appear to influence acceptability of self-sampling, problems related to fear of the diagnosis should still be addressed when trying to implement self-administered cervicovaginal sampling. In this study, self-sampling was found to be a very acceptable tool even before it was carried out. The results also suggest that age and ethnicity are important predictors in this study to determine preference for self-sampling. When planning a community-based model for cervical cancer prevention, the involvement and proper management by the local government administration and community leaders is vital for its success. This was exemplified in the work by 130 communities in China.42 A similar approach should be considered so that the resources, planning and massive screening is carried out efficiently and successfully in Malaysia.

Study strengths and limitations

One of the strengths of this study is its large sample size and the diversity of the population surveyed in terms of social and demographic characteristics. However, the findings might not accurately represent the whole Malaysian population because the participants mostly consist of women in urban areas from a developed state and not women in rural areas. Furthermore, the study population was recruited from women who came to the health centres, resulting in those unable to come because of logistical barriers being missed. Thus, the results represented women who had reasonable healthcare access. Despite this, nearly 40% had not previously received a Pap test, indicating that access alone does not completely explain the poor screening participation rates in Malaysia. However, because of this design feature, further studies are needed to assess the attitudes of the rural Malaysian population towards self-administered cervicovaginal sampling and its acceptability, as this may represent one of the feasible alternatives to broad screening in remote areas. It is possible even with our findings in women who have access to healthcare and hospitals that others in rural areas might not necessarily find self-sampling acceptable for different reasons such as traditional mind sets or cultural taboos.

Conclusion

This study, which examined the acceptability of self-administered cervicovaginal sampling among Malaysian women, has shown encouraging results. Overall, Malaysian women from different backgrounds found the self-sampling method to be an acceptable alternative to traditional Pap smears, hence increasing the options for expanded cervical cancer prevention strategies in this population.

Acknowledgments

We would like to thank the participants of this study, the doctors, nurses and support staff in Klinik Kesihatan Pandamaran, Klinik Kesihatan Ampang, Klinik Kesihatan Bandar Botani, Klinik Kesihatan Batu 9, and University Malaya Medical Centre for their support, and Khoo Su Pei and Syahirah Binti Shaharudin for assistance with patient recruitment.

Footnotes

Contributors: YLW, NB-P, PG and JB contributed to the overall design of the study. MM, NHN, SS, YM and P-PG contributed to patient recruitment. MM, NB-P and YLW drafted the manuscript. MM, S-HY and NB-P performed the data analysis. All authors read, amended and approved the final manuscript.

Funding: This study was funded by the Ministry of Higher Education, Malaysia, under a High Impact Research/Ministry of Higher Education Grant (number UM.0000068/HIR.C1), University of Malaya Research Grant (UMRG RP029A-14HTM) and a research grant from Merck Sharp and Dohme (Malaysia). The ‘Just for Me’ self-samplers were donated by Preventive Oncology International.

Competing interests: YLW received a study grant from Merck Sharp and Dohme (Malaysia) Sdn Bhd to support the MyHPV prevalence study.

Ethics approval: University of Malaya Medical Centre Ethics Committee.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data sharing statement: No additional data are available.

References

  • 1.Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917. 10.1002/ijc.25516 [DOI] [PubMed] [Google Scholar]
  • 2.Lim GCC RS, Yahaya H. Cancer Incidence in Peninsular Malaysia, 2003–2005: the Third Report of the National Cancer Registry, 2008. http://www.moh.gov.my/images/gallery/Report/Cancer/CancerIncidenceinPeninsularMalaysia2003-2005x1x.pdf (accessed 30 July 2016).
  • 3.Nor M, Safiza N, Khor GL et al. The Third National Health and Morbidity Survey (NHMS III) 2006: nutritional status of adults aged 18 years and above. Malays J Nutr 2008;14:1–87.22691761 [Google Scholar]
  • 4.Othman NH, Devi BC, Halimah Y. Cervical cancer screening: patients understanding in major hospitals in Malaysia. Asian Pac J Cancer Prev 2009;10:569–74. [PubMed] [Google Scholar]
  • 5.Petignat P, Vassilakos P. Is it time to introduce HPV self-sampling for primary cervical cancer screening? J Natl Cancer Inst 2012;104:166–7. 10.1093/jnci/djr544 [DOI] [PubMed] [Google Scholar]
  • 6.Oranratanaphan S, Amatyakul P, Iramaneerat K et al. Knowledge, attitudes and practices about the Pap smear among medical workers in Naresuan University Hospital, Thailand. Asian Pac J Cancer Prev 2010;11:1727–30. [PubMed] [Google Scholar]
  • 7.Baskaran P, Subramanian P, Rahman RA et al. Perceived susceptibility, and cervical cancer screening benefits and barriers in Malaysian women visiting outpatient clinics. Asian Pac J Cancer Prev 2013;14:7693–9. 10.7314/APJCP.2013.14.12.7693 [DOI] [PubMed] [Google Scholar]
  • 8.Ezat SW, Hod R, Mustafa J et al. National HPV immunisation programme: knowledge and acceptance of mothers attending an obstetrics clinic at a teaching hospital, Kuala Lumpur. Asian Pac J Cancer Prev 2013;14:2991–9. 10.7314/APJCP.2013.14.5.2991 [DOI] [PubMed] [Google Scholar]
  • 9.Health Facts. In: Malaysia MoH, editor. Health Informatics Centre Planning and Development Division, 2012. http://www.moh.gov.my/images/gallery/stats/heal_fact/health_fact_2012_page_by_page.pdf (accessed 30 July 2016).
  • 10.Othman NH, Rebolj M. Challenges to cervical screening in a developing country: the case of Malaysia. Asian Pac J Cancer Prev 2009;10:747–52. [PubMed] [Google Scholar]
  • 11.Haguenoer K, Sengchanh S, Gaudy-Graffin C et al. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial. Br J Cancer 2014;111:2187–96. 10.1038/bjc.2014.510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gravitt PE, Belinson JL, Salmeron J et al. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 2011;129:517–27. 10.1002/ijc.25974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Boers A, Bosgraaf RP, van Leeuwen RW et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer 2014;111: 1095–101. 10.1038/bjc.2014.392 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bosgraaf RP, Verhoef VM, Massuger LF et al. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer 2015;136:646–55. [DOI] [PubMed] [Google Scholar]
  • 15.Sowjanya AP, Paul P, Vedantham H et al. , Community Access to Cervical Health Study Group. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2009;18:1373–8. 10.1158/1055-9965.EPI-08-1171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Piana L, Leandri FX, Le Retraite L et al. [HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhone]. Bull Cancer 2011;98:723–31. [DOI] [PubMed] [Google Scholar]
  • 17.Sancho-Garnier H, Tamalet C, Halfon P et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013;133:2681–7. [DOI] [PubMed] [Google Scholar]
  • 18.Bosgraaf RP, Ketelaars PJ, Verhoef VM et al. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med 2014;64:108–13. 10.1016/j.ypmed.2014.04.011 [DOI] [PubMed] [Google Scholar]
  • 19.Virtanen A, Nieminen P, Niironen M et al. Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol 2014;135:487–94. 10.1016/j.ygyno.2014.09.019 [DOI] [PubMed] [Google Scholar]
  • 20.Penaranda E, Molokwu J, Flores S et al. Women's attitudes toward cervicovaginal self-sampling for high-risk HPV infection on the US-Mexico border. J Low Genit Tract Dis 2015;19:323–8. 10.1097/LGT.0000000000000134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gustavsson I, Lindell M, Wilander E et al. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol 2009;46:112–16. 10.1016/j.jcv.2009.06.021 [DOI] [PubMed] [Google Scholar]
  • 22.Waller J, McCaffery K, Forrest S et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006;13:208–13. [DOI] [PubMed] [Google Scholar]
  • 23.Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88–93. 10.1038/sj.bjc.6600974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Howell-Jones R, Bailey A, Beddows S et al. Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer 2010;103:209–16. 10.1038/sj.bjc.6605747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wong EL, Chan PK, Chor JS et al. Evaluation of the impact of human papillomavirus DNA self-sampling on the uptake of cervical cancer screening. Cancer Nurs. 2016;39:E1–E11. 10.1097/NCC.0000000000000241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ozyer S, Uzunlar O, Ozler S et al. Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination. Asian Pac J Cancer Prev 2013;14:4877–81. 10.7314/APJCP.2013.14.8.4877 [DOI] [PubMed] [Google Scholar]
  • 27.Ferdous J, Islam S, Marzen T. Attitude and practice of cervical cancer screening among the women of Bangladesh. Mymensingh Med J 2014;23:695–702. [PubMed] [Google Scholar]
  • 28.Assoumou SZ, Mabika BM, Mbiguino AN et al. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health 2015;15:37 10.1186/s12905-015-0193-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kim HW, Kim DH. Awareness of cervical cancer prevention among mothers of adolescent daughters in Korea: qualitative research. BMJ Open 2015;5:e006915 10.1136/bmjopen-2014-006915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Latiff LA, Rahman SA, Wee WY et al. Assessment of the reliability of a novel self-sampling device for performing cervical sampling in Malaysia. Asian Pac J Cancer Prev 2015;16:559–64. 10.7314/APJCP.2015.16.2.559 [DOI] [PubMed] [Google Scholar]
  • 31.Crofts V, Flahault E, Tebeu PM et al. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health 2015;7:149–54. 10.2147/IJWH.S56307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Guan Y, Castle PE, Wang S et al. A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect 2012;88:490–4. 10.1136/sextrans-2012-050477 [DOI] [PubMed] [Google Scholar]
  • 33.Chen SL, Hsieh PC, Chou CH et al. Determinants of women's likelihood of vaginal self-sampling for human papillomavirus to screen for cervical cancer in Taiwan: a cross-sectional study. BMC Womens Health 2014;14:139 10.1186/s12905-014-0139-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dzuba IG, Diaz EY, Allen B et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gender Based Med 2002;11:265–75. [DOI] [PubMed] [Google Scholar]
  • 35.Anhang R, Nelson JA, Telerant R et al. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) 2005;14:721–8. 10.1089/jwh.2005.14.721 [DOI] [PubMed] [Google Scholar]
  • 36.Kahn JA, Bernstein DI, Rosenthal SL et al. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect 2005;81:408–14. 10.1136/sti.2004.012047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Karwalajtys T, Howard M, Sellors JW et al. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006;82:337–9. 10.1136/sti.2005.019430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Safaeian M, Kiddugavu M, Gravitt PE et al. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis 2007;34:429–36. 10.1097/01.olq.0000243623.67673.22 [DOI] [PubMed] [Google Scholar]
  • 39.Forrest S, McCaffery K, Waller J et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen 2004;11:85–8. 10.1258/096914104774061065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Szarewski A, Cadman L, Ashdown-Barr L et al. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen 2009;16:193–8. 10.1258/jms.2009.009069 [DOI] [PubMed] [Google Scholar]
  • 41.Padela AI, Peek M, Johnson-Agbakwu CE et al. Associations between religion-related factors and cervical cancer screening among Muslims in greater Chicago. J Low Genit Tract Dis 2014;18:326–32. 10.1097/LGT.0000000000000026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Belinson JL, Wang G, Qu X et al. The development and evaluation of a community based model for cervical cancer screening based on self-sampling. Gynecol Oncol 2014;132:636–4. 10.1016/j.ygyno.2014.01.006 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2015-011022supp.pdf (85.2KB, pdf)


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES